Back to results
US 2024/0190851 A1Published application
Furan fused ring-substituted glutarimide compound
AssigneeMedshine Discovery Inc.
InventorsMaoyi LEI, Junmiao LI, Shuhui CHEN
Life of this patent
Estimating the term…
Abstract
Disclosed are a series of furan fused ring-substituted glutarimide compounds and an application thereof in preparation of a drug for treating related diseases. In particular, disclosed is a compound represented by formula (II) or a pharmaceutically acceptable salt thereof.
Claims11
A compound of formula (II) or a pharmaceutically acceptable salt thereof,
- wherein
- PTM is selected from a drug or a derivative thereof that binds to an AR targeted protein;
- L1 is selected from —(CH2)n—, and each CH2 is optionally replaced by R1;
- R1 is selected from C3-7 cycloalkyl, 6-membered heterocycloalkyl, —NRa—, —CRbRc—, —CH2CH2O—, and —NHC(═O)—;
- Ra is selected from H and C1-3 alkyl;
- Rb and Rc are each independently selected from H, D, and F;
- E1 is selected from a single bond and O;
- ring A is absent;
- or ring A is selected from phenyl and 5-membered heteroaryl;
- n is selected from 1, 2, 3, 4, 5, and 6;
- the 6-membered heterocycloalkyl and 5-membered heteroaryl contain 1, 2, or 3 heteroatoms or heteroatom groups independently selected from —NH—, —O—, —S—, and N, respectively;
- provided that the compound is not selected from:
9 more elements
A compound of the following formulas or a pharmaceutically acceptable salt thereof, which is selected from:
Dependencies are inferred from the claim text.